|
|
||||||||
RAPID COMMUNICATION |
a Stem Cell Research Group, Giving for Living Postgraduate Centre, Royal Manchester Childrens Hospital, Manchester, United Kingdom;
b Laboratory Medicine, Stepping Hill Hospital, Poplar Grove, Stockport, United Kingdom;
c Willink Biochemical Genetics Unit, Royal Manchester Childrens Hospital, Manchester, United Kingdom;
d Cancer Research UK Gene Therapy Group, Paterson Institute for Cancer Research, Christie Hospital, Manchester, United Kingdom
Key Words. Mesenchymal stem cells • Transplantation
Correspondence: Ilaria Bellantuono, Ph.D., Stem Cell Research Group, Giving for Living Postgraduate Centre, Royal Manchester Childrens Hospital, Manchester, United Kingdom, M27 4HA. Telephone: 44-161-7272385; Fax: 44-161-7272679; e-mail: Ilaria.Bellantuono{at}cmmc.nhs.uk
Human marrow stromal cells (MSCs) can be isolated from bone marrow and differentiate into multiple tissues in vitro and in vivo. These properties make them promising tools in cell and gene therapy. The lack of a specific MSC marker and the low frequency of MSCs in bone marrow necessitate their isolation by in vitro expansion prior to clinical use. This may severely reduce MSC proliferative capacity to the point that the residual proliferative potential is insufficient to maintain long-term tissue regeneration upon reinfusion. In this study we determined the effect of in vitro expansion on the replicative capacity of MSCs by correlating their rate of telomere loss during in vitro expansion with their behavior in vivo. We report that even protocols that involve minimal expansion induce a rapid aging of MSCs, with losses equivalent to about half their total replicative lifespan.
This article has been cited by other articles:
![]() |
J. Ma, M. Shi, J. Li, B. Chen, H. Wang, B. Li, J. Hu, Y. Cao, B. Fang, and R. C. Zhao Senescence-unrelated impediment of osteogenesis from Flk1+ bone marrow mesenchymal stem cells induced by total body irradiation and its contribution to long-term bone and hematopoietic injury Haematologica, July 1, 2007; 92(7): 889 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Mueller, J. Luetzkendorf, T. Mueller, K. Reichelt, H. Simon, and H.-J. Schmoll Presence of Mesenchymal Stem Cells in Human Bone Marrow After Exposure to Chemotherapy: Evidence of Resistance to Apoptosis Induction Stem Cells, December 1, 2006; 24(12): 2753 - 2765. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Berger, R. Veyrat-Masson, C. Rapatel, S. Descamps, J. Chassagne, and N. Boiret-Dupre Cell Culture Medium Composition and Translational Adult Bone Marrow-Derived Stem Cell Research Stem Cells, December 1, 2006; 24(12): 2888 - 2890. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tamama, V. H. Fan, L. G. Griffith, H. C. Blair, and A. Wells Epidermal Growth Factor as a Candidate for Ex Vivo Expansion of Bone Marrow-Derived Mesenchymal Stem Cells Stem Cells, March 1, 2006; 24(3): 686 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-S. Tsai, S.-M. Hwang, Y.-L. Tsai, F.-C. Cheng, J.-L. Lee, and Y.-J. Chang Clonal Amniotic Fluid-Derived Stem Cells Express Characteristics of Both Mesenchymal and Neural Stem Cells Biol Reprod, March 1, 2006; 74(3): 545 - 551. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
